Windtree Therapeutics Stock (NASDAQ: WINT) stock price, news, charts, stock research, profile.
You can purchase shares of Windtree Therapeutics (NASDAQ:WINT) through any online brokerage.
Other companies in Windtree Therapeutics’s space includes: Tharimmune (NASDAQ:THAR), Synaptogenix (NASDAQ:SNPX), Quoin Pharmaceuticals (NASDAQ:QNRX), Palisade Bio (NASDAQ:PALI) and TransCode Therapeutics (NASDAQ:RNAZ).
Windtree Therapeutics has a consensus price target of $7.00.
The stock price for Windtree Therapeutics (NASDAQ: WINT) is $0.37 last updated December 18, 2024 at 4:31 PM EST.
There are no upcoming dividends for Windtree Therapeutics.
Windtree Therapeutics’s Q3 earnings are confirmed for Wednesday, November 27, 2024.
There is no upcoming split for Windtree Therapeutics.
Windtree Therapeutics is in the Health Care sector and Biotechnology industry. They are listed on the NASDAQ.